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Overexpression of lymphotoxin in T cells induces fulminant
thymic involution
Abstract
Activated lymphocytes and lymphoid-tissue inducer cells express lymphotoxins (LTs), which are
essential for the organogenesis and maintenance of lymphoreticular microenvironments. Here we
describe that T-cell-restricted overexpression of LT induces fulminant thymic involution. This
phenotype was prevented by ablation of the LT receptors tumor necrosis factor receptor (TNFR) 1 or LT
beta receptor (LTbetaR), representing two non-redundant pathways. Multiple lines of transgenic
Ltalphabeta and Ltalpha mice show such a phenotype, which was not observed on overexpression of
LTbeta alone. Reciprocal bone marrow transfers between LT-overexpressing and receptor-ablated mice
show that involution was not due to a T cell-autonomous defect but was triggered by TNFR1 and
LTbetaR signaling to radioresistant stromal cells. Thymic involution was partially prevented by the
removal of one allele of LTbetaR but not of TNFR1, establishing a hierarchy in these signaling events.
Infection with the lymphocytic choriomeningitis virus triggered a similar thymic pathology in wt, but
not in Tnfr1(-/-) mice. These mice displayed elevated TNFalpha in both thymus and plasma, as well as
increased LTs on both CD8(+) and CD4(-)CD8(-) thymocytes. These findings suggest that enhanced T
cell-derived LT expression helps to control the physiological size of the thymic stroma and accelerates
its involution via TNFR1/LTbetaR signaling in pathological conditions and possibly also in normal
aging.
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Activated lymphocytes and lymphoid-tissue inducer
cells express lymphotoxins (LTs), which are essential
for the organogenesis and maintenance of lymphore-
ticular microenvironments. Here we describe that T-
cell-restricted overexpression of LT induces fulminant
thymic involution. This phenotype was prevented by
ablation of the LT receptors tumor necrosis factor re-
ceptor (TNFR) 1 or LT beta receptor (LTR), represent-
ing two non-redundant pathways. Multiple lines of
transgenic Lt and Lt mice show such a phenotype,
which was not observed on overexpression of LT
alone. Reciprocal bone marrow transfers between LT-
overexpressing and receptor-ablated mice show that
involution was not due to a T cell-autonomous defect
but was triggered by TNFR1 and LTR signaling to ra-
dioresistant stromal cells. Thymic involution was par-
tially prevented by the removal of one allele of LTR but
not of TNFR1, establishing a hierarchy in these signal-
ing events. Infection with the lymphocytic choriomen-
ingitis virus triggered a similar thymic pathology in wt,
but not in Tnfr1/mice. Thesemice displayed elevated
TNF in both thymus and plasma, as well as increased
LTs on both CD8 and CD4CD8 thymocytes. These
findings suggest that enhanced T cell-derived LT expres-
sion helps to control the physiological size of the thy-
mic stroma and accelerates its involution via TNFR1/
LTR signaling in pathological conditions and possibly
also in normal aging. (Am J Pathol 2008, 172:1555–1570;
DOI: 10.2353/ajpath.2008.070572)
The efficient output of lymphocytes from the thymus follow-
ing positive and negative selection is crucial for efficient
adaptive immune responses. The thymus generates a T-cell
repertoire essential for adaptive immunity during embryo-
genesis and throughout life.1 T-cell precursors generated
from hematopoietic stem cells in the bone marrow (BM)
enter the thymus under chemotactic guidance. A complex
maturation process involving interactions between thymo-
cytes and the thymic stroma ensures self-tolerance: most
autoreactive thymocytes are eliminated by negative selec-
tion before exiting the thymus.2
Impaired responses to pathogens and to altered self-
antigens have been recognized as contributing to the aging
of the immune system in many mammalian species.3–7 Age-
dependent involution of the thymus parallels the age-related
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deterioration of immune responses.8 In male C57BL/6 mice,
thymic involution starts at the age of 8 to 12 weeks and
results in a thymic rudiment after 6 to 8 months. In females
this process is delayed.7,9 In humans, thymic involution
occurs between the first and fourth decades of life.10 The
key factors and cellular mechanisms driving involution are
poorly understood.11,12
Lymphotoxins (LTs) are expressed by activated T, B, and
NK cells,13,14 as well as by CD45CD3CD4CXCR5
lymphoid tissue inducer cells (LTi cells).15 LTs and related
tumor necrosis factor (TNF)-family cytokines are essential
for the development and maintenance of secondary lym-
phoid organs and for appropriate immunological
functions.16–22
Membrane-bound LT consists of heterotrimeric com-
plexes of LT and LT (LT12 or LT21), whereas
secreted LT (sLT) is homotrimeric.23–25 LT heterotrimers
signal via LT receptor (LTR), whereas sLT signals
mainly via the TNF receptors, TNFR1 and TNFR2.14,26
LT is inducible in B and T cells, whereas LT mRNA is
constitutively expressed.14,23,27 LT signaling is essential
to the differentiation and function of high endothelial
venules28,29 and ectopic LT expression can induce lym-
phoid neogenesis at atypical sites including kidney, pan-
creas, and liver.30,31 The cellular and molecular require-
ments for the establishment of lymph nodes and
inflammation-associated neolymphoid structures are sim-
ilar. In the latter, hyperactivated lymphocytes appear to
be able to fulfill the role of LTi cells.15
LT signaling deficiencies can lead to alymphoplasia,
yet do not significantly prevent thymic development, thy-
mic structure, T cell differentiation, and negative selec-
tion.16–22,32–35 However, LTR signaling was found to
control normal differentiation of thymic medullary epithe-
lial cells via cross talk between thymocytes and thymic
medullary epithelial cells,36 and to regulate  T cell
differentiation in concert with other factors.37 LTR plays
an important role in thymic negative selection of organ-
specific thymocytes through thymic medullary chemo-
kine regulation.38 Thymic homeostasis and atrophy might
be controlled or influenced by changes in homeostatic
chemokines and cytokines.6,7,39,40 Administration of pro-
inflammatory cytokines and steroids can drive thymic
involution.4–7,12,39 T-cell specific expression of the ligand
for herpesvirus entry mediator and LTR induces lym-
phoid tissue abnormalities that affect the thymus.41 En-
hanced levels of TNF after lipopolysaccharide or con-
canavalin A treatment may cause a similar phenotype,40
whereas Tnfr1/ ablation delays age-dependent thymic
involution.42
Naı¨ve T cells do not express membrane-bound or sol-
uble LT,21,43 yet up-regulate both forms on activation.
LT receptors are expressed by thymic stroma, suggest-
ing a role for LT signaling in lymphocyte-stromal interac-
tions. We tested the latter hypothesis by constitutively
expressing LTs on T cells. This conferred a CD44high
phenotype to T cells, indicative of an activated state, and
induced fulminant thymic involution. A similar phenotype
was detected in wt mice, but not in Tnfr1/ or Ltr/
mice, on adoption of tgLt BM. Hence this thymic pa-
thology resulted from signaling to thymic stroma rather
than from impaired thymocyte homing.44,45 We further
investigated the effects of a lymphocytic choriomeningitis
virus (LCMV) infection with strain WE (LCMV-WE) or strain
Docile (LCMV-DOCILE) on thymic homeostasis. Infection
of wt but not Tnfr1/ mice with LCMV also led to preco-
cious thymic involution and up-regulation of LT on CD8
and CD4CD8 thymocytes. This suggests that LTR
and TNFR1 signaling by T cells contributes to thymic




Animals were free of all bacterial, viral, and parasitic
pathogens listed in the Federation of European Labora-
tory Animal Science Associations recommendations and
were maintained under specific pathogen-free condi-
tions. Housing and experimental protocols were in accor-
dance with the Swiss Animal Protection Law and mice
were held according to the law of the Veterina¨ramt, Kan-
ton Zu¨rich. Lt/, Lt/, Tnfr1/, Tnfr2/, Ltr/,
and JH/ mice were published previously.19,20,34,35,46
Generation of tg Constructs
A pBluescript II KS (3.0 kbp) vector with a deleted KpnI
restriction site in the multiple cloning site was used. The
vector was linearized with BamHI/SalI and a BamHI/SalI
restriction product (5.6 kbp) of the PrP 5HG con-
struct47 was cloned in (KpNI pBluePrP 5HG construct).
Lck-promoter cassette (3.1 kbp) was isolated by digest
with BamHI and NotI of the pPrP5HGLckSalI construct47
and subsequent purification on a 0.7% agarose gel by
gel extraction (Qiagen). The full Lt and Lt open reading
frames were amplified from a pLt and pLt plasmids
using primers that incorporate 50 or 15 bp overhangs
with homologous sequences to the Prnp cDNA, incorpo-
rating the genuine anti-thymocyte globulin of the Prnp
locus of the PrP 5HG construct47 and a restriction site for
MfeI and KpnI. PCR products were 610 bp for Lt and
921 bp for Lt.
Primers used for LT-Prnp overhangs are as follows.
LT primer forward: 5-CGGGGTACCAGTCCAATTTAG -
GAGAGCCAAGCAGACTATCATCATGACACTGCTCGG-
CCGTCTCC-3. LT primer forward: 5-CGGGGTA-
CCAGTCCAATTTAGGAGAGCCAAGCAGACTATCATCA-
TGGGGACAGGGGACTGCAGG-3. LT primer reverse:
5-CCACCTCAATTGAATCTACAGTGCAAAGGCTCC-3.
LT primer reverse: 5-CCACCTCAATTGAATTCAC-
CCCACCATCACCGC-3. Ten PCR products of each
cDNA were pooled, purified by gel extraction (Qiagen,
according to the manufacturer’s manual), and partially
digested with KpnI and MfeI. Digested PCR products
were repurified and used for subcloning into a MfeI/KpnI
linearized KpNI pBluePrP 5HG vector. After successful
subcloning of both LT cDNAs, control digests and se-
quencing of LT and Lt open reading frames and flank-
ing regions (ABI Prism Sequencer) were performed.
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These KpNI pBluePrP 5HGLt or Lt vectors were
linearized with BamHI and NotI for the insertion of the
promoter cassette. The purified lck-promoter47 was
cloned into the KpNI pBluePrP 5HGlck Lt (13.0kpb) or
KpNI pBluePrP 5HGlck Lt (13.3 kbp) vectors. All re-
striction enzymes used were purchased from Roche and
New England Biolabs.
The LT open reading frame and insertion sites of the
lck-promoter were sequenced. Both vectors were linear-
ized with a SalI, NotI digest leading to linearized PrP
5HGlck Lt (9.0 kpb), or HG-lck Lt (10 kbp). Fragments
were isolated on a 0.7% agarose gel by the gel extraction
method (Qiagen, according to the manufacturer’s man-
ual) and used for male pronucleus micro-injection.
Genomic Southern Blot
Mouse tail biopsies were received in liquid nitrogen and
digested in a lysis buffer containing 100 mmol/L Tris-HCl
(pH 8.5), 5 mmol/L EDTA, 0.2% SDS, 20 mmol/L NaCl,
100 g proteinase K/ml overnight at 55°C with constant
rotation. Twenty g of purified genomic DNA were di-
gested overnight (EcoRI 100 units), and separated over-
night on a 0.7% agarose (GIBCO BRL) gels. Genomic
digest and DNA separation was checked by ethidium
bromide staining. Genomic DNA was depurinated by
treatment with 1M HCL for 15 minutes and 0.4M NaOH for
30 minutes and transferred to Hybond-N membranes
(Amersham) in 0.4M NaOH overnight by capillary blotting
technique. Optionally, vacuum blotting was performed at
50 to 55 mbar with a Vacu Gene Pump and a Gene XL
blotting apparatus (Pharmacia Biotech) and solutions
were used according to the manufacturer’s manual
(Pharmacia). After the agarose gel was examined for
residual DNA, the blot was marked, washed for 5 minutes
in 2 standard saline citrate buffer, UV-crosslinked, and
prehybridized according to Church and Gilbert.48 After
hybridization overnight at 65°C with a radioactively la-
beled probe (LT or LT open reading frame), the blot
was washed and subjected either to autoradiography
using X-ray films (Kodak) or a PhosphorImager (Molecu-
lar Dynamics). Exposed images from the PhosphorIm-
ager were analyzed with a scanner (Aida) and signals
were quantified with the Aida 2.41 imaging analysis
program.
Probe Labeling
Template DNA (50 ng) was diluted in sterile water, and
random primer (Nonamers or Hexamers) were added
(Stratagene). After gentle mixing and incubation at 95°C
for 5 minutes, short centrifugation was followed by 3
minutes incubation on ice. This was followed by addition
of 5 Primer-buffer (dCTP), radioactive labeled 32P-
dCTP (corresponding to the 25 Ci/Amersham Bio-
sciences), and Klenow 5 u/l (Prime-IT II). For primer
elongation, the probe was incubated on 37°C for 75
minutes. All work with radioactivity was performed in an
area designated for radioactive work.
Probe Purification
For purification a QIAquick PCR-purification kit was used,
according to the manufacturer’s manual (Qiagen).
Adding the Radioactive Probe to the Membrane
Ten l sonicated salmon sperm (Stratagene) were added
to the radioactively labeled, purified probe, per ml hybrid-
ization solution (final concentration 100 g/ml). The mix-
ture was incubated at 95°C for 5 minutes, briefly centri-
fuged, and chilled on ice for 3 minutes before being
added to the prehybridized membrane (2 hours at 65°C).
PCR Specific for tg(Lt), tg(Lt), and
tg(Lt)Mice
Mouse tail-lysates (2.5 l) were used. For tg LT the
following primers were used: Forward primer (Primer 1):
5-CTGAGTATATTTCAGAACTG-3, and reverse primer
(Primer 2): 5-CAGAGAAAACCACCTGGGAG-3. For tg
LT the following primers were used: Forward primer
(Primer 4): 5-CTGAGTATATTTCAGAACTG-3 and re-
verse primer (Primer 5): 5-GAGTCTCTGAGAGGCTA-
GAG-3. The following PCR conditions were established
on a Gene Amp PCR System 9700 PCR machine (Ap-
plied Biosystems): 95°C 60 seconds denaturation; 55°C
50 seconds annealing; and 72°C 50 seconds elongation;
for 35 cycles; followed by 72°C 7 minutes shoot out, and
4°C forever cool down.
RNase Protection Assays
Mice were sacrificed with CO2. Thymi, spleens, Peyer’s
patches, and lymph nodes were removed. Total RNA was
isolated using TRIzol reagent (Life Technologies) follow-
ing the manufacturer’s recommendations. Chemokine
mRNA levels were determined using the Riboquant Mul-
tiprobe RNase Protection Assay system (BD PharMin-
gen). 32P-labeled riboprobes were synthesized from a
customized plasmid template set using T7 polymerase.
The DNA template was digested with DNase and total
RNA (15 g) was hybridized with the riboprobes over-
night at 56°C. Single-stranded RNA species were re-
moved by digestion with RNase A. The protected RNA
species were phenol/chloroform extracted, ethanol pre-
cipitated, and electrophoresed on a 5% polyacrylamide
gel. Protected chemokine probes were visualized by au-
toradiography of the dried gel.
Preparation of Mouse-Tail Lysates for PCR
Analysis
For PCR screening of mice, 5 mm of the tail were cut and
lysed in 250 l lysis buffer containing 50 mmol/L Tris-HCl
(pH 9.0), 0.5% Nonidet P-40, 0.5% Tween 20, and 0.1
mg/ml proteinase K, at 55°C with agitation overnight at
600 rpm (Thermomixer 5436, Eppendorf). Following com-
plete digestion, proteinase K was then inactivated by
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incubation at 95°C for 10 minutes. After centrifugation
(12,000 rpm/15 minutes/room temperature) the lysates
were immediately used for PCR (2.5 l/PCR reaction) or
stored at 20°C.
Histology and Immunohistochemistry
Frozen sections from thymus (5 m), lymph nodes, or
spleen were stained with H&E. Antibodies FDC-M1 (clone
4C11; 1:50, Becton Dickinson), CD35 (8C12, PharMin-
gen, San Diego, CA), and anti-CD45RO/B220 (RA3-6B2,
PharMingen) were used. CD4 for T-helper cells (clone
YTS 191; 1:200) and CD8 for cytotoxic T cells (clone YTS
169; 1:50), both rat anti-mouse, were kindly provided by
R. Zinkernagel.49 Nonlymphocytic dendritic cells-145 for
dendritic cells (Biomedic AG; BMA, Switzerland, T-2013;
1:1000), peanut agglutinin for germinal-center B cells
(Vector L-1070; 1:100), and F4/80 (Serotec, 1:50) for
macrophages were visualized using standard methods.
CK5, CK18, Ulex europeaus agglutinin-1 (UEA-1), and
mouse thymus stroma-10 and 24 (MTS10 and MTS24) for
confocal microscopy were used as described.50 Termi-
nal deoxynucleotidyl transferase-mediated dUTP staining
was performed according to the manufacturer’s protocol
(Oncor).
BM Chimeric Mice
BM cells were isolated from tibiae and femurs, and 5 to
10  106 BM cells were injected into tail veins of 8 to
10-week-old recipients conditioned by whole-body irra-
diation (1100 rad) 24 hours earlier as described.51 Six to
eight weeks after grafting, reconstitution was assessed
by fluorescence-activated cell sorting (FACS) analysis of
peripheral blood taken from the retro-orbital plexus of
ether-anesthetized mice. Blood samples were prepared
at 4°C in buffer solution (PBS containing 2% fetal calf
serum and 0.2% NaN3). Reconstitution efficiency was
checked in parallel reconstitutions where wt mice re-
ceived BM from mice expressing the green fluorescent
protein under the chicken albumin promoter.52
FACS Analysis
Detection of surface LT12 on B and T lymphocytes: 1 to
5 million lymphocytes from spleen, mesenteric lymph
nodes (MLN), or thymus were centrifuged at 1500 rpm for
10 minutes and washed in FACS buffer (PBS, 1 mmol/L
EDTA, 0.1% Na Azide, 2% fetal calf serum) followed by
incubation with 25 l of Fc-block (anti-CD16/32 1:100
from PharMingen) in FACS buffer for 15 minutes on ice.
Twenty-five l of diluted LTR-Fc fusion protein were
added directly to the Fc-block and incubated for 30
minutes on ice. This was followed by a washing step
(twice) in 200 l of FACS buffer. The anti-human-Fc an-
tibody (biotin: 109-0635-008; Jackson Immunoresearch)
was preabsorbed for 30 minutes with 2% normal mouse
and 2% normal rat serum (Sigma) to reduce the back-
ground. The biotin anti-human-Fc antibody was diluted
1:200 and after washing, a streptavidin-phycoerythrin la-
beled antibody (PharMingen) was added.
This procedure was followed by staining with lineage
marker antibodies resuspended in normal mouse and rat
serum at 1 to 2%. For T cell and B cell specific stains
antibodies against CD4, CD8, CD19, and B220 (PharM-
ingen; fluorescein isothiocyanate [FITC[-labeled) were
used. Two- and three-color FACS analyses were per-
formed on a FACSCalibur (Becton Dickinson) as de-
scribed.51 The following anti-mouse antibodies were used
(all PharMingen): peridinin chlorophyll-a protein-labeled an-
ti-B220, FITC-labeled anti-CD21, phycoerythrin-labeled an-
ti-CD23, phycoerythrin-anti-CD8, FITC-anti-CD4, phyco-
erythrin-anti-CD11b, FITC-anti-CD8, Annexin V, and FoxP3.
7-Amino-actinomycin D (7-AAD) analysis was performed
using a FACSCalibur using CELLQuest software (Becton
Dickinson). Postacquisition analysis was performed using
WinMDI 2.8 software and FlowJo (Institute for Neuropathol-
ogy). FACS analysis and quantification of early T lineage
progenitors (ETPs) was performed as described.53
Northern Blot Analysis and in Situ Hybridization
Northern blot analysis and in situ hybridization of frozen
spleen sections were performed as previously de-
scribed.54 The following cDNA probes were used: B-
lymphocyte chemoattractant (nucleotides 6 to 762, Gen-
Bank AF044196), secondary lymphoid organ chemokine
(nucleotides 10 to 784, GenBank U88322), stromal cell-
derived factor-1 (nucleotides 34 to 687), macrophage-
derived chemokine (nucleotides 13 to 567), EBV-induced
molecule 1 ligand CC chemokine (nucleotides 15 to 750),
and complete murine GAPDH. Total RNA was prepared
using TRIzol reagent (Life Technologies), and multiprobe
RNase protection assay using different probe set (BD
PharMingen) was performed according to manufacturer’s
recommendations.
RT-PCR
Total thymic, splenic, or lymph nodal RNA from wt and
tgLT/ mice were isolated in TRIzol reagent (Life Tech-
nologies) and reverse transcribed using the GeneAmp kit
(Roche) according to the manufacturer’s instructions. Pu-
rified RNA was DNase treated according to the manufac-
ture’s manual (Roche). Reverse transcribed cDNA (Ge-
neAmp kit; Roche) of total thymic, splenic, or lymph nodal
RNA from wt and tg mice was used for Taq-Man PCR.
Transgene specific probes for LT and LT were gener-
ated as follows: Taq-man PCR for LT: 5 Prp Taq: 5-
CCAATTTAGGAGAGCCAAGCA-3 and 3 LT Taq: 5-
TGCCAAGCACCCTCAAGAG-3. LT specific probe: 5-
CATCATGACACTGCTCGGCCGTCT-3. Labeling of the
probe was conducted as follows (reporter, 6-carboxyfluo-
rescein; quencher, 6-carboxytetramethylrhodamin): Taq-
man PCR for LT: 5 Prp Taq: (the same primer as for
LT). 3 LT Taq: 5-CTGCCACAGCCAGCAAGA-3.
Probe: 5-CAGGCCCTGCAGTCCCCGTG-3. As control
for Taq-Man PCR procedure and possible DNA contam-
ination DNase treated RNA from wt and tg mice that was
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not reverse transcribed was used. Taq-Man PCR was
performed on an ABI Prism 7700 Sequence detector.
Cytokine Assays
Thymi were placed in 10 vol of Tris-HCl buffer (50
mmol/L, pH7.4) with NaCl (0.6 M), Triton X-100 (0.2%),
and bovine serum albumin (0.5%) containing freshly dis-
solved protease inhibitors: benzamidine (1 mmol/L), ben-
zethonium chloride (0.1 mmol/L), and phenylmethylsulfo-
nyl fluoride (0.1 mmol/L). Samples were homogenized
(TissueTearor; BioSpec Products, Bartlesville, OK) for 10
seconds, sonicated (Vibra Cell; Sonics & Materials, New-
town, CT) for 20 seconds at 10 mV, and centrifuged at
12,000 rpm for 20 minutes at 4°C. The supernatants were
aliquoted and frozen at 80°C until the cytokine assays
were performed. Cytokine protein levels in the serum and
thymic homogenates were measured using a multiplexed
particle-based flow cytometric cytokine assay (Vignali,
2000). Fluorokine Multi Analyte Profiling mouse kit for
TNF was purchased from R&D Systems (Wiesbaden-
Nordenstadt, Germany). The procedures closely followed
the manufacturer’s instructions. The analysis was con-
ducted using a conventional flow cytometer (LSRII von Bec-
ton Dickinson). The detection limit for TNF was 0.4 pg/ml.
Enzyme-Linked Immunosorbent Assay for LT3,
LT12, and LT21
For enzyme-linked immunosorbent assay (ELISA), a
Nunc Immuno Maxi-Sorp plate was coated with 0.1M
Na2HPO4, pH9 at room temperature for 2 hours. After
removal of 0.1M Na2HPO4, 100 l/well of the respective
10% organ homogenate was added, and the plate was
sealed and incubated over night at 4°C. Next, the plate
was washed three times with PBS/0.05% Tween, incu-
bated in blocking buffer with 10% fetal calf serum/PBS
(filtered in 0.22 m) for 2 hours at room temperature, and
subsequently washed six times with PBS/0.05% Tween.
One hundred l of the primary antibody (MAB-748; R&D;
1:1000 diluted in blocking buffer/Tween (0.05%) were
added and incubated in the sealed plate for 90 minutes
at room temperature or overnight at 4°C. After subse-
quent washing six times with PBS/0.05% Tween, the sec-
ondary antibody (Dako #E0468) was diluted 1:2000 in
blocking buffer/Tween (0.05%), 100 l were added/well,
and the plate was sealed for 1 hour at room temperature.
After subsequent washing six to eight times with PBS/
0.05% Tween, a strepavidin-HRP complex (Biosource
SNN2004; 0.95 mg/ml) was diluted 1:40,000 fold in block-
ing buffer/Tween (0.05%) and 100 l were added/well.
The plate was sealed and incubated at room temperature
in the dark. After subsequent washing six to eight times,
100 ml of stabilized Chromogen BioSourceSBo1 was
added and the plate was incubated at room temperature,
wrapped in aluminum-foil, and incubated on a shaker for
color development for 5 to 30 minutes. The reaction was
stopped by adding 50 l stop solution (0.5M H2S04)-
color of positive wells turns yellow. The optical density of
the wells was read at 405 nm on a conventional ELISA
reader. For the establishment of a standard curve we
used recombinant-murine “generic” LT consisting of
both LT21 and LT3 (kindly provided by Dr. Jeffrey
Browning, Biogen Idec, Inc.) or recombinant mouse Lt
(Cat.No.749-TB/CF; R&D) (0.5 g/100 l to 7 ng/100 l).
For negative control homogenates derived from LT/
mice were used. In our hand the detection limit/back-
ground was 15 ng/well.
Quantification of Relative Thymus Weight and
Absolute Cell Number
For the analysis of relative thymus weight, body weight of
the respective mice was weighted before thymi of differ-
ent tg, wt, and knockout mice were isolated by microsur-
gery. Afterward, isolated thymi were weighted and thymic
lobes were smashed to isolate connective tissue and fat
from total thymic cells. Cells were diluted in PBS 1:10,
1:100, and 1:1000 and counted in a modified Neubauer
chamber, as well as a CASY cell counter (Scha¨rf Sys-
tems). For quantification of absolute thymic cells the av-
erage of at least three independent counting rounds was
used.
Viruses and Peptides
The LCMV, WE strain, originally obtained from Dr. F.
Lehmann-Grube (Hamburg, Germany), was propagated
on L929 cells at a low multiplicity of infection and was
plaqued as previously described.55 The LCMV-GP pep-
tide KAVYNFATM (gp33) and the LCMV-NP peptide
FQPGNGQFI (np396) were purchased from Neosystem
(Strasbourg, France). Virus infection was performed with
LCMV-WE (200 plaque-forming units) or LCMV-DOCILE
(2  106 plaque-forming units). For densitometric analy-
sis the Soft Imaging System AnalySISD (Olympus) was
used.
Analysis of Insulin-Like Growth Factor-1
and Growth Hormone Serum Levels
Serum insulin-like growth factor (IGF)-I levels were mea-
sured by double-antibody IGF binding protein-blocked
radioimmunoassay.56 Mouse growth hormone (GH) was
measured by using a radioimmunoassay (RPA 551; Am-
ersham) with a detection range of 1.3 to 100 ng/ml.
LCMV-NP Specific ELISA
The LCMV nucleoprotein-specific ELISA has been de-
scribed previously using LMCV-NP expressed by Spo-
doptera frugiperda 9 (Sf9) cells after infection with a re-
combinant baculovirus.
Footpad Swelling Reaction
The indicated amounts of LCMV-WE were injected in a
volume of 50 ml in balanced salt solution into both hind
footpads in experimental groups of three mice. The foot-
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pad thickness was measured at the indicated time points
with a spring-loaded caliper.
Construction of Tetrameric Class I-Peptide
Complexes and Flow Cytometry
MHC class I (H-2Db) tetramers complexed with gp33
were produced as previously described. Briefly, H2-Db
and human b2-microglobulin molecules were recombi-
nantly expressed in E. coli (the plasmids were kindly
provided by John Altman, Emory University, Atlanta, GA).
Biotinylated H2-Db peptide complexes were purified us-
ing and A´kta Explorer 10 chromatography system (Phar-
macia, Sweden) and tetramerized by addition of strepta-
vidin-phycoerythrin (Molecular Probes, Eugene, OR). At
the indicated time points after immunization, animals
were bled and single cell suspensions were prepared of
spleen and lymph nodes. Aliquots of 5  105 cells or
three drops of blood were stained using 50 ml of a
solution containing tetrameric class I-peptide complexes
at 37°C for 10 minutes followed by staining with anti-CD8-
FITC (PharMingen) at 4°C for 20 minutes. Erythrocytes in
blood samples were lysed with FACS lysis solution (Bec-
ton Dickinson) and the cells were analyzed on a FACS-
can flow cytometer (Becton Dickinson) after gating on
viable leukocytes. For the determination of absolute cell
counts, the number of total viable leukocytes was as-
sessed in an improved Neubauer chamber. For blood,
the number of total viable leukocytes was automatically
determined in an Advia counter (Bayer, Germany).
Results
Homo- and Heterotrimeric LT is Increased in
Transgenic Thymi
Transgenic (tg) mice expressing LT or LT under tran-
scriptional control of the distal lck promoter57,58 (Figure
1A) were generated by pronuclear microinjection, and
screened by Southern blot analysis (Figure 1B). In addi-
tion, double tg mice expressing both LT and LT were
generated by co-injecting both constructs. Four tg(Lt)
founder mice out of 35 offspring from microinjected zy-
gotes, 5 tg(Lt) out of 53, and 4 tg(Lt) out of 19 were
identified by Southern blot and PCR analysis to harbor
the respective transgenes (Figure 1B and data not
shown). Two independent tg(Lt), three independent
tg(Lt), and two independent tg(Lt) lines were ob-
tained that expressed and passed the tg on to their
progeny with a Mendelian ratio of approximately 50%
(Table 1). For each construct, two lines were further bred
for experimentation: tg(Lt)856 and 857, tg(Lt)54 and
57, as well as tg(Lt)19 and 44.
RNase protection assays showed increased overall LT
and/or LT mRNA expression in thymus, MLN, Peyer’s
patches, and to a lesser extent in spleen of tgLt and LT
single tg mice (Figure 1C and data not shown). Statistical
analysis of three independent RPA experiments revealed a
significant up-regulation of LT and LT mRNA in thymus
(LT: P 0.02 and LT: P 0.03), MLN (LT: P 0.01 and
LT: P  0.03) and spleen (LT: P  0.05 and LT: P 
0.04) as evaluated for lines tg(Lt)856 and 857. Magnetic
activated cell sorting was performed to analyze LT and
LT mRNA expression in enriched CD4 or CD8 thymic T
cells of tg and wt mice. An increase in mRNA expression of
LT (16- to 32-fold) and LT (7- to 16-fold) was detected in
tgCD4 T cells. In tgCD8 T cells a less pronounced in-
crease was detected (LT: 5- to 16-fold; LT: 4- to 10-fold)
(see Supplemental Figure S1A at http://ajp.amjpathol.org).
We also investigated the expression of additional TNF family
members and cytokines in various organs. TGF3 mRNA
expression was increased three- to fivefold in thymus and
MLN of tgLtmice. Importantly, TNF, TNFR1, and TNFR2
mRNA expression were unchanged (Figure 1C and see
Supplemental Figure S1B at http://ajp.amjpathol.org). Ex-
pression of membrane bound LT12 protein was analyzed
by flow cytometry of B and T cells from 6-week-old
tg(Lt)856 (green), wt (dark purple), and Lt/ (pink)
naı¨ve mice. Tg CD4 and CD8 cells expressed 5- to
40-fold more LT12 in thymus, MLN, and spleen, when
compared with wt T cells (Figure 1D, upper and middle
row). B220/CD19 cells gated from MLN or spleen of wt
and tg mice did not express increased LT12 levels (Fig-
ure 1D, lower panels). In contrast to wt thymi, tg thymi
contained B220/CD19 DP populations, which were pos-
itive for LT12 (Figure 1D). Therefore, tg LT expression
was restricted to T cells with LT12 expressing B cells in tg
thymi.
With the currently available tools we analyzed homo-
and heterotrimeric LT expression by ELISA in organ ho-
mogenates of 6 to 8-week-old mice. Thymi, MLNs, and
spleens of lines tg(Lt)856, 857 and tg(Lt)54 and 57
showed detectable LT expression. In contrast, we could
hardly detect homo- and heterotrimeric LT expression in
wt mice and lines tg(Lt)19 and 44 (Figure 1 E and data
not shown), and spleens and thymi of Lt/ lacked
detectable LT expression. In the following we will mainly
focus on line tg(Lt)856. Lines tg(Lt)857, tg(Lt)54
and 57 displayed identical or very similar phenotypes.
tg(Lt)19 and 44 lacked an overt phenotype and be-
haved like wt mice in all experiments described below.
Enhanced Expression of LT on T Cells Induced
Accelerated Thymic Involution
We analyzed the time course of the expression of LT and
other TNF family members in wt and tg(Lt)856 thymi by
RPA followed by quantitative fluoroscopy (Figure 2A).
LT and LT transcripts were up-regulated 10-fold in
tgLt thymi at postnatal day 1 (P1). At P7 LT and LT
were overexpressed 15-fold and 3-fold, respectively,
and remained increased two- to fourfold over wt mice at
all time points thereafter (Figure 2A).
Tg thymi were normal in size at P1 (Figure 2B, females:
P  0.059; males: P  0.70), confirming the absence of
a primary anlage defect. However, the thymic weight—
both in absolute terms and as ratio to body weight—was
drastically reduced at P7 and P14 (P  0.008, Figure 2C
and see Supplemental Figure S2A at http://ajp.amj-
1560 Heikenwalder et al
AJP June 2008, Vol. 172, No. 6
Figure 1. Generation and characterization of tg mice expressing T cell derived LT. A: Schematic representation of tgLT and tgLT constructs used for
pronuclear microinjection on the basis of the 5HG expression cassette.58 Arrows 1 to 6 indicate various primers used for PCR and RT-PCR analysis (see
Material and Methods). B: Genomic Southern blot analysis identified founder mice positive for tgLt, tgLt or DP for tgLt. LT or LT, endogenous (end.)
and transgenic (tg) LT or LT EcoRI fragments detected by a radioactively labeled probe. kbp: kilobase pairs C: RPA showing increased LT and LT
mRNA expression in spleen, thymus, MLN, and Peyer’s patches of double and single tg mice (lines: tg(Lt)856 and tg(Lt)54). TNF, IL6, IFN, IFN TGF1,
TGF2, and MIF mRNA expression levels remained unchanged. tgLt thymi mice displayed a three- to fivefold up-regulation of TGF3 mRNA. D:
Histogram of FACS analysis for LT12 expression on T (CD4
 and CD8) and B cells (B220/CD19) in spleen, thymus, and MLN. Green lines depict
tg(Lt)856, purple fill Lt/ and pink line wt mice. B220/CD19 cells positive for LT12 were detected in tg thymi. E: Analysis of LT21, LT12,
and LT3 in organ homogenates (thymus, spleen, MLN) of various transgenic lines, wt mice, and Lt
/ mice by ELISA, reveals the presence of LT3 in
tgLt and tgLt lines but not in Lt/ mice.
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pathol.org), and reduced to rudiments at P42 and at all
time points thereafter until P336 (P  0.001).
In view of the above results we evaluated LT and 
mRNA expression by Taq-Man analysis in wt thymi of older
age (3, 6, and 18 months). For control, thymi of Lt/ and
Lt/ mice were used (n  3; data not shown). We found
a modest increase in LT and LT mRNA expression in
thymi of wt mice over time ranging from two- to eightfold
(see Supplemental Figure S2B at http://ajp.amjpathol.org),
which was significant at 6 and 18 months of age (6 months
of age: LT, P  0.02; LT, P  0.03; 18 months of age:
LT, P  0.01; LT, P  0.03).
Because cortisol, IGF-I, and GH may contribute to thymic
involution,5 we assessed the serum levels of these hor-
mones in tgLt and wt littermates at the age of 6 weeks
(n  3 to 4 each). No differences were detected in serum
levels of cortisol (tgLt: 17	 3 nmol/L; wt: 18	 4 nmol/L),
IGF-I (tgLt: 312 	 20 ng/ml; wt: 324 	 31 ng/ml; n  4
each), and GH (female tgLt: 44	 17 ng/ml; male tgLt:
49	 21 ng/ml; female wt: 41	 14 ng/ml; male wt: 46	 28
ng/ml; three males and three females each).
Abnormal T Cell Development in tg Thymi
Flow cytometry of tgLt thymocytes derived from pooled
thymi (P42) revealed a decrease of double-positive (DP)
CD4CD8 T cells (wt: 83 to 86%; tgLt: 11 to 29%).
The relative prevalence of CD8 T cells was higher in
tgLt (7 to 12%) than in wt mice (3 to 5%), yet their
absolute number was significantly reduced (P  0.01,
Figure 2D and see Supplemental Figure S2C at http://
ajp.amjpathol.org). This was confirmed by quantification
of total thymocytes (see Supplemental Figure S2C at
http://ajp.amjpathol.org). A relative increase was also de-
tected in CD4CD8 double-negative (DN) cells (wt: 5 to
9%; tgLt: 68 to 81%; Figure 2D). Absolute numbers of
DN T cells were reduced in tgLt (n  4) (0.45  107 	
0.1  107 cells/thymus) when compared with wt thymi
(n  4) (0.3  108 	 0.15  108 cells/thymus; P 
0.001M and see Supplemental Figure S2C at
http://ajp.amjpathol.org).
Tg thymi contained relatively increased CD44highCD4
and CD44highCD8 T cell subsets (Figure 2D, right pan-
els, and see Supplemental Figure S2D and S2E at http://
ajp.amjpathol.org). Also, DN CD25CD44 thymocytes
were hyperprevalent, whereas DN CD25CD44 thymo-
cytes were decreased in tgLT thymi (Figure 2D and
see Supplemental Figure S2E at http://ajp.amjpathol.org,
middle column).
To distinguish the various DN T cell subsets (DN1-
DN4) from other populations in the thymus (eg, B cells,
NK cells) we have excluded Lin thymocytes by mag-
netic activated cell sorting and analyzed Lin thymocytes
of tgLt and wt thymi (n  3 each) by flow cytometry
analysis (Figure 2E). A significant reduction of Lin cells
within tgLT thymi was observed (tgLT: 0.25 107 	
0.1  107 cells/thymus; wt: 0.45  108 	 0.1  108
cells/thymus; P  0.001). There was a slight decrease in
the absolute number of tgLt DN1 T cells (n 3; 0.73
106 	 0.11  106 cells/thymus) when compared to wt
mice (n  4; 0.85  106 	 0.1  106 cells/thymus; P 
0.5), and a highly significant reduction of DN2, DN3, and
DN4 T cells (P  0.001; 
2 log-fold reduction in all
cases). FACS analysis for LT12 revealed transgene
expression in the DN3 and DN4 populations of tgLT
mice (data not shown).
Thymic early T lineage progenitors (LinCD25CD44c-
kit ETPs) undergo depletion in aged mice.53 We found
significant depletion of ETPs already in 6-week-old tgLT
thymi (n  4; tgLt: 0.15  105 	 0.1  105; n  3; wt:
0.5  105 	 0.2  105; n  3; P  0.02).
The peripheral blood of tgLt mice contained fewer
total leukocytes (P  0.03), CD4 T cells (P  0.001),
and CD8 T cells (P  0.002; see Supplemental Figure
S3A and B at http://ajp.amjpathol.org). This was accom-
panied by a relative increase of CD44high lymphocytes
(P  0.02) (see Supplemental Figure S3D and C at
http://ajp.amjpathol.org).
Histological examination of the tgLt thymic micro-
architecture revealed a conspicuous reduction of cortical
areas already at P1 (Figure 3), well before the onset of
discernible involution, with concomitant enlargement of
the medullary compartment (Figure 3 and 4A) as as-
sessed with antibody anti-MTS10. The latter was even
more pronounced at P42 (MTS10area mm2/20 mm2
thymic tissue: P1: tgLt: 6 	 1.5, wt: 3 	 0.4, P  0.03;
P42: tgLt: 13 	 2, wt: 3.5 	 0.8, P  0.001).
We further investigated whether the MTS24 precur-
sors of medullary and cortical stromal cells were
changed in tgLt mice.50 MTS24 staining was 10-
fold increased in tgLt thymi at 6 weeks of age (Figure
4B). A similar increase was detected in lines tg(Lt)857,
tg(Lt)54, and tg(Lt)57, thereby excluding any integra-
tional artifacts (Figure 4B). The strong increase in
MTS24 staining was not detected at P14 in any tg
mouse lines (data not shown) and must therefore must
have developed between P14 and P42. No significant
difference in the number of UEA-1 medullary epithelial
cells was detected between tgLt (P  0.6) or tgLt
(P  0.7) and wt thymi (Figure 4C). Normal differentiation
of thymic medullary epithelial cells into medullary cells in
thymi of tgLt mice was observed (see Supplemental
Table 1. List of tg Lines and Transgene Copy Numbers
tg construct(s) tg line tg copy number
LckLt tg(Lt) 6 tgLt 19
tg(Lt) 8 tgLt 1
tg(Lt) 54 tgLt 1
tg(Lt) 57 tgLt 4
LckLt tg(Lt) 19 tgLt 1
tg(Lt) 20 tgLt 14
tg(Lt) 31 tgLt 7
tg(Lt) 44 tgLt 1
tg(Lt) 47 tgLt 7
LckLt and LckLt tg(Lt) 855 tgLt 4/tgLt 5
tg(Lt) 856 tgLt 2/tgLt 2
tg(Lt) 857 tgLt 6/tgLt 4
Lines marked in bold gave rise to tg-positive offspring, which
expressed the tg and transmitted the tg in a Mendelian ratio. Number
of tg copies was evaluated by phosphor-imaging and was quantified in
relation to the signal that was the result of both endogenous alleles.
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Figure 4 at http://ajp.amjpathol.org) and confocal mi-
croscopy of the cortico-medullary junction failed to
reveal differences in the organization of CK5 thymic
medullary epithelial cells and CK18 thymic cortical
cells (see Supplemental Figure S5A at http://ajp.
amjpathol.org).
The autoimmune regulatory element (Aire), expressed
by the thymic stroma was reported to be regulated by
the lymphotoxin pathway.59 We investigated the im-
pact of T cell derived LT on the Aire mRNA expres-
sion in the thymic stroma by RT-PCR analysis of tgLt
and wt thymi at various time points. Aire mRNA expres-
sion was similar in tgLt and wt mice at 3, 6, and 9
weeks of age (see Supplemental Figure S5B at http://
ajp.amjpathol.org).
LT Induced Thymic Involution in tgLt Mice
Depends on LTR and TNFR1 Signaling
LT3 and LT12 signal mainly through TNFR1 and
TNFR2, and through LTR, respectively.14,26 Hence thy-
mic involution may result from signaling through any of
these receptors. We therefore crossed tgLt mice to
receptor-deficient mice (Figure 5). Additionally, we tested
whether B cells participate in thymic involution by cross-
ing tgLt and B-cell deficient JH/ mice.19,20,34,35,60–62
Thymic pathology was prevented in Tnfr1/ and Ltr/,
but not in Tnfr2/, Lt/, Lt/, and JH/ mice (all 6
to 7 weeks old; n  4 each; Figure 5A and see Supple-
mental Figure S6A at http://ajp.amjpathol.org), as as-
sessed by thymus weight (tgLt vs. Tnfr1/ x tgLt or
Figure 2. Macroscopic and cellular character-
ization of thymic involution in tgLt mice. A:
RNA expression of LT and various cytokines
using RPA during postnatal development (P1 to
P42). One representative experiment out of
three for each time point is shown. LT and LT
were up-regulated in tg thymi during early post-
natal development and in adult mice. B: Macro-
scopic analysis of postnatal thymus develop-
ment in tgLt mice and negative littermates.
Thymic involution of tg mice can be detected
between P7 and 42 (scale bar: 1 mm). C: Time
course of alterations in relative thymus weight
(ie, thymus weight with respect to body weight).
Each time point is the mean of at least 3 mice
analyzed. Onset of thymic involution in male
C57BL/6 mice is earlier than in C57BL/6 female
mice.7 tg thymi start involuting between postna-
tal day 7 and 14. D: FACS analysis of tg and wt
thymi at P42. Numbers indicate the percentage
of the respective cell populations. Pooled tgLt
thymi (n 3 to 4) (lower row) show a reduction
in DP T cells and an inverted CD4:CD8 ratio. A
representative experiment from four is shown.
E: FACS analysis of Lin DN thymocytes of
tgLt and wt thymi (n  4).
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Ltr/ x tgLt, P  0.001), absolute number of thymo-
cytes (Figure 5B-C), and distribution of DP, DN, and single-
positive (SP) T cells (Figure 5D). These data indicate that
LT3 is expressed in tg mice and that it participates in the
induction of the thymic phenotype.
Increased Annexin V/7-AAD DP Cells in tg
Thymi
We investigated whether accelerated thymic involution in
tgLt mice results from apoptosis (n  4). Flow cytom-
etry for Annexin V and 7-AAD revealed a strong increase
of apoptotic 7-AAD/Annexin V positive cells in tg thymi
(P28–42) (Figure 6A): Annexin V SP cells, indicative of
apoptotic cells, increased from 1.4 	 0.3% in wt thymi to
18 	 8% in tgLt thymi (P  0.002). Annexin V/7-AAD
DP cells increased from 1.3 	 0.2% in wt to 5.5 	 2% in
tgLt thymi (P  0.01). Increased apoptosis of tgLt
thymi was also confirmed by positive terminal deoxynu-
cleotidyl transferase-mediated dUTP staining of histolog-
ical cryosections from wt and tgLt thymi, revealing a
highly significant increase in the number of positive cells,
mainly in the cortical areas of the thymus (data not
shown). We densitometrically analyzed the area of posi-
tivity mm2/10 mm2 of various thymus sections from indi-
vidual mice (n  3) at 3 and 6 weeks of age (2 weeks:
tgLt: 0.78 	 0.2 mm2/10 mm2; wt: 0.13 	 0.04 mm2/10
mm2, P 0.005 and 6 weeks: tgLt: 0.38	 0.3 mm2/10
mm2; wt: 0.15 	 0.09 mm2/10 mm2, P  0.01).
Stromal TNFR1 and LTR Signaling Induce
Thymic Involution
Thymic involution may be caused by autocrine effects of
LTs onto T cells, or by destruction of the thymic TNFR1
and LTR stroma via tgLt T cells.44,45 To address this
question, we generated BM chimaeras whose LT signal-
ing defects (either in TNFR1 or LTR signaling) were
confined to the stromal compartment.
Wt3wt, tgLt3wt; wt3tgLt; tgLt3Tnfr1/ and
tgLt3Ltr/ chimeric mice were generated (n  4
each; Figure 6B). These mice were either competent or
deficient for TNFR1 or LTR-mediated signaling in thymic
stromal cells, whereas their hematopoietic compartment
was either tgLt or wt. Reconstitution experiments were
controlled by transplanting BM of -ActGFP mice63 into
lethally irradiated wt mice, which led to 95 to 98% recon-
stitution, as assessed by flow cytometry of peripheral
blood cells (n  3; data not shown).
Figure 3. Analysis of thymic microenvironment in tg mice. Immunohisto-
chemical analysis of tg and wt thymi at P1. Even though no obvious macro-
scopic differences were observed at P1, tg thymic cortex was already reduced
and thymic medulla enlarged (asterisks). Scale bar: 200 m.
Figure 4. Increase in MTS24 staining in tgLt mice. A: H&E staining of wt,
tgLt, or tgLt mice showing the relative enlargement of the thymic med-
ullary compartment in tg mice when compared to wt mice. Scale bar: 400 m.
B: Confocal microscopy of thymi cryosections stained for CK5, CK18, and
MTS24 were performed to investigate medullary and cortical micro-architec-
ture by confocal microscopy. No apparent differences were observed by CK5
and CK18 staining. However, an increase in MTS24 staining was observed
in tg mice. Scale bar: 50 m. C: Confocal microscopy of tg and wt thymi
stained for UEA-1 and CK18 were performed. No differences in the distribu-
tion pattern or UEA-1/CK18 double positivity were observed between wt and
tgLt or tgLt mice. Scale bar: 50 m.
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Figure 5. T cell triggered thymic involution is induced via TNFR1 and LTR
signaling. A: Macroscopic analysis of thymi from various knockout mice
crossed to tgLt mice (6 to 8 weeks old). Backcrossing to Tnfr1/ and
Ltr/ mice rescued the thymic phenotype due to LT overexpression on
T cells. Scale bar: 2 mm. B and C: Quantitative analysis of relative thymic
weight and absolute number of thymocytes from these crossing experiments
confirmed this observation. D: FACS analysis of tgLt x Tnfr1/ or tgLt
x Ltr/ mice reveals an amount of SP CD4 and CD8, DP CD4CD8
and DN CD4CD8 T cell populations in thymus comparable to wt mice. A
representative of three independent experiments is shown.
Figure 6. Stromal TNFR1 and LTR signaling triggered by tg T cells is
responsible for thymic involution in tgLt mice. A: Flow cytometric analysis
of total thymus cells for Annexin V and 7-AAD was performed to investigate
the magnitude of apoptosis in pooled tg (n  3) and wt thymi (n  3). A
representative of three independent experiments is shown. B: Macroscopic
analysis of thymi from mice reconstituted by BM transplantation from several
genotypes: wt BM into wt, tg BM into wt, Tnfr1/, or Ltr/mice. Transfer
of tgLt BM cells into wt mice induced thymic involution. In contrast, tgLt
BM failed to induce thymic involution in Tnfr1/ and Ltr/ mice. C and
D: Quantitative analysis of relative thymic weight and absolute number of
thymocytes from the respective crossing experiments revealed prevention of
the thymic, hypoplastic phenotype, particularly in Tnfr1/mice. E: Analysis
of thymic micro-architecture confirmed normal distribution of CD4 and
CD8 T cells in Tnfr1/ or Ltr/mice crossed to tgLtmice. Scale bars:
50 m (left 2 columns) and 200 m (right 2 columns).
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Reconstitution of wt mice with tgLt BM led to thymic
rudimentalization and micro-architectural pathologies simi-
lar to those observed in tgLt mice (Figure 6B and E),
whereas reciprocal reconstitution (wt3tgLt) did not re-
vert macroscopic thymic involution, absolute number of thy-
mocytes, or relative thymic weight (Figure 6B-D). In con-
trast, the absolute numbers of thymocytes and relative
thymus weights of wt3wt chimaeras were similar to those of
aged-matched (12 to 14 weeks) wt mice (Figures 6C-D and
see Supplemental Figure S6B at http://ajp.amjpathol.org).
Tnfr1/ mice reconstituted with tgLt BM developed
a normally sized thymus with number of thymocytes com-
parable to unreconstituted wt or Tnfr1/ mice, in con-
trast to wt mice reconstituted with tgLt BM (tgLt3wt
vs. tgLt3Tnfr1/: P  0.002) (Figure 6B-E and (see
Supplemental Figure S7 at http://ajp.amjpathol.org).
Therefore, stromal TNFR1-mediated signaling in non-he-
matopoietic thymic stromal cells induces thymic involu-
tion in the presence of tgLt BM cells (Figure 6B).
Similar results were observed in tgLt BM3Ltr/ chi-
meras. We could observe an unaltered thymus size, relative
thymic weight (tgLt3wt vs. tgLt3Ltr/:P  0.007),
absolute number of thymocytes (Figure 6C-D), and undis-
turbed thymic micro-architecture (Figure 6E), when com-
pared with wt mice that were reconstituted with tgLt BM.
These data suggest that thymic stromal TNFR1 and LTR
signaling pathways synergistically cause precocious thy-
mic involution. Interestingly, crossings of tgLt with
Tnfr1/ and Ltr/ mice revealed that thymic involution
can be partially prevented with one allele of LTR but not
with one allele of TNFR1 in tgLt mice (see Supplemental
Figure S7 at http://ajp.amjpathol.org).
T Cell-Derived LT Modulates T Cell-Dependent
Immune Response in vivo
TgLt mice showed hypoplastic thymi with reduced num-
bers of thymic and peripheral CD4 and CD8 T cells. To
study the functional significance of this phenotype, we in-
vestigated the immune response of tg mice on viral infec-
tion. We intravenously challenged tgLt, tgLt, and wt
mice (n  4 each) with 200 plaque-forming units of LCMV-
WE. Organs were taken 9 days post-infection and the effi-
ciency of viral clearance was assessed by a plaque assay
for LCMV-WE. In primary and secondary lymphoid organs
(thymic rudiment, MLN, and spleen) the clearance of
LCMV-WE was not as efficient as in wt controls (see Sup-
plemental Figure S8A at http://ajp.amjpathol.org). Injection
of LCMV-WE into footpads of mice led to markedly reduced
footpad swelling in tgLt mice than in tgLt or wt mice,
indicating inefficient local CD8 T cell response (see Sup-
plemental Figure S8B at http://ajp.amjpathol.org). Despite
this mitigated inflammatory response, the immunoglobulin
class switch for antibodies specific for the LCMV nuclear
protein (np396) remained unaltered (see Supplemental Fig-
ure S8C at http://ajp.amjpathol.org). Reduced activity of
LCMV-specific T cells and reduced LCMV-WE specific
CD8 T cells were found by direct ex vivo killer assays in
MLN, spleen, and blood (see Supplemental Figures S8D
and 9 at http://ajp.amjpathol.org).
LCMV Infection Induces Acute Thymic
Involution
Thymic involution of tgLt mice with concomitant in-
crease of CD44 expression on CD4 and CD8 T cells
resembled a T cell activation phenotype. We therefore
asked whether LCMV infection per se may induce thymic
involution. Wt mice (n  4 each) were infected with
LCMV-WE or LCMV-DOCILE. Given the stronger viru-
lence of LCMV-DOCILE when compared to LCMV-WE64
we anticipated a more pronounced effect in LCMV-DOC-
ILE infected animals.
Age matched, untreated wt mice (n  4) served as
controls. Mice were sacrificed at 9 days post-infection,
and thymi were investigated for size, weight, thymocyte
cellularity, and micro-architecture. Macroscopically thy-
mus size was reduced in LCMV-WE infected wt mice and
even more drastically in LCMV-DOCILE infected wt mice
when compared to untreated, age-matched controls (8
weeks old). (Figure 7A). Thymic involution was confirmed
by quantification of the relative thymus weight and abso-
lute cell number of thymocytes (Figure 7A and 7B). His-
tological analysis revealed disturbance of the thymic mi-
cro-architecture of LCMV infected wt mice with a
reduction of the thymic cortex and a relative enlargement
of the thymic medulla similar to what was observed in
tgLt mice (Figure 7C). The relative enlargement of the
thymic medulla was densitometrically analyzed in
LCMV-WE and LCMV-DOCILE infected animals (n  4
each; 4 step cuts/mouse). Similar to tgLT mice at P42
we observed a significant relative enlargement of the
thymic medulla after infection with both, LCMV-WE and
LCMV-DOCILE (MTS10area mm2/20 mm2 thymic tissue:
LCMV-WE: 8.5	 2.5, wt not-infected: 4.5	 1.5, P 0.02;
LCMV-DOCILE: 12.5 	 3.5, wt not-infected: 4.5 	 1.5,
P  0.003).
We noted that TNF levels were increased in sera and
thymi of LCMV-DOCILE- and LCMV-WE-infected mice
(Figure 7D and data not shown). We further investigated
whether blocking of TNFR1 signaling could prevent thy-
mic involution after LCMV-DOCILE infection. Tnfr1/
mice were infected with LCMV-DOCILE and compared to
infected and uninfected wt mice (n  4 each, female and
male). Infected Tnfr1/ mice displayed increased TNF
levels similarly or slightly higher to infected wt mice (n 
3) (Figure 7D). Infected wt mice displayed a drastic re-
duction of relative thymic weight and absolute thymo-
cytes regardless of the sex of the infected mice (Figure
7E and F). Female Tnfr1/ mice infected with LCMV-
DOCILE displayed significantly less thymic involution
than infected wt mice (P  0.01), whereas rescue was
marginal in male Tnfr1/ mice (P  0.12).
Following LCMV-WE or LCMV-DOCILE infection,
LT12 expression was increased on the surface of
CD8 thymocytes and to lesser degree on DN
CD4CD8 T cells as investigated by flow cytometry
analysis (Figure 7G and data not shown). In addition, we
investigated homo- and heterotrimeric LT protein expres-
sion in thymic homogenates of LCMV-WE or LCMV-DOC-
ILE infected animals at 9 days post-infection. We could
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observe an increase in LT expression in thymic homog-
enates of LMCV-WE or LCMV-DOCILE infected mice but
not in control C57BL/6 mice (see Supplemental Figure
S10 at http://ajp.amjpathol.org).
This was accompanied by a reduction in the absolute
number of DP thymic T cells of wt mice infected with
LCMV-WE or LCMV-DOCILE (42 to 71%; P  0.01) when
compared to uninfected wt mice (81 to 84%). In contrast SP
CD4 and CD8 T cells were increased in relative and
absolute numbers in LCMV-WE infected mice (infected
CD4 T cells: 13 to 34%, P 0.01; CD8 T cells: 6 to 13%,
P  0.03; uninfected CD4 T cells: 6 to 9%; CD8 T cells: 3
to 5%). Moreover, primed, tetramer (gp33-reactive) positive
CD8 T cells, indicative of viral specific T cells that re-
Figure 7. Viral infection induces thymic involution and LT expression on T cells that is partially rescued in Tnfr1/ mice. A and B: Reduction in relative thymic
weight and absolute number of thymocytes in wt mice infected LCMV-WE, detected to greater extent in wt mice infected with LCMV-DOCILE at day 9
post-infection. C: Immunohistochemistry analysis of thymi from LCMV-DOCILE infected wt mice and controls revealed a reduction of the thymic cortex. Scale
bar  200 m. D: Increased levels of TNF in serum and thymus protein homogenate of LCMV-DOCILE infected wt and Tnfr1/ mice. E and F: Partial rescue
of thymic involution in Tnfr1/ female mice and to a lesser degree in Tnfr1/ male mice, as compared with uninfected wt mice or wt mice infected with
LCMV-DOCILE. G: FACS analysis of thymi of LCMV-WE infected and non-infected wt mice. Thymus DP cells are reduced in LCMV-WE infected wt mice, whereas
SP CD4 and CD8 T cells are increased. Histograms gated on CD8 T cells indicate a strong up-regulation of LT12 in 2 out 3 of thymi from LCMV-WE infected
wt mice, and weak up-regulation in the third one. Interestingly, a similar but reduced effect was also detected on DN CD4CD8 thymocytes.
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entered, were detected at 9 days post-infection in thymi of
LCMV-WE-infected wt mice (see Supplemental Figure S10A
and B at http://ajp.amjpathol.org).
The prevalence of gp33-specific CD8 T cells in thymus
(1.5 to 3% of all thymic gated CD8 T cells) was lower than
in spleen (9 to 12% of all splenic gated CD8 T cells) (see
Supplemental Figure S10A at http://ajp.amjpathol.org). In
LCMV-DOCILE infected mice the amount of tetramer posi-
tive CD8 T cells was less pronounced in spleen and thy-
mus (data not shown). Accordingly, the absolute and rela-
tive number of splenic CD8 T cells was only slightly, not
significantly increased when compared to uninfected wt
mice (data not shown). As reported earlier at that time point
exhaustion of T cells in spleen and thymus of LCMV-DOC-
ILE infected mice could already be detected (64 and data
not shown).
Discussion
Here we investigated the functional consequences of
chronic overexpression of LT by T cells on thymus devel-
opment and homeostasis. Multiple lines of tgLt and
tgLt mice showed accelerated thymic involution, aber-
rant T cell development, and changes in thymic micro-
architecture. None of these pathologies were observed
on overexpression of LT alone, suggesting that LT,
whose expression is tightly controlled in T cells, is crucial
to the phenotype described.65 Overexpression of T cell-
derived LT did not lead to an increase of cortisol, IGF-I, or
GH serum levels,66,67 indicating that the pathologies
were not mediated by these hormones.
SP CD4 and CD8 thymic tgLt T cells, as well as
CD4CD8 cells, were significantly reduced. Despite
their relative increase within tgLt thymic rudiments, the
absolute numbers of DN T cells were also decreased. A
breakdown of Lin DN T cell subsets in tgLt mice
revealed a slight reduction of DN1 and a strong reduction
of DN2, DN3, and DN4 T cell subsets.
ETPs, a subset of the DN1 T cell subset, are thought to
reflect the developmental potential in the thymus53 and
decrease over time in parallel with the progressively re-
duced thymic regenerative potential.53 We found that
tgLt thymi hosted fewer ETPs, similarly to aged wt
thymi.53 Thymic atrophy of tgLt went along with a
strong reduction of the thymic cortex and a relative en-
largement of the thymic medullary compartment, again
reminiscent of age-related thymic involution.
MTS24 cells, which are precursors of medullary and
cortical stromal cells, were increased in thymi of tgLt
and tgLt mice. This increase was observed at the peak
of involution (P42) but not at birth, suggesting that it
represents a compensatory mechanism.
Thymic involution was rescued by removal of either
TNFR1 or LTR, but not of TNFR2, LT, LT, or B cells (as
in JH/ mice). This indicates that pathology is mediated
by two non-redundant pathways: LT3 signaling through
TNFR1, and LT12 signaling through LTR. No up-reg-
ulation of TNF mRNA was observed in tgLt thymus
and MLN.
What is the mechanism of thymic pathology? LT over-
expression may conceivably lead to the cell-autonomous
premature demise of thymocytes, thereby depleting the
thymus of immature T cells. Alternatively, LT-expressing T
cells may induce thymic involution by engaging pro-
apoptotic receptors on thymic stromal cells. This ques-
tion was clarified with reciprocal BM transplants. Thymic
involution occurred in tgLt3wt mice, but was pre-
vented in tgLt3Tnfr1/ chimeric mice. Therefore
tgLt T cells primarily targeted the thymic stromal com-
partment, presumably via LT3. In view of phenotype of
tgLt  Tnfr2/ mice, LT33TNFR2 signaling seems
irrelevant in this context.
Membrane-bound LT12 mainly signals via LTR.
Thymic involution was rescued in tgLt3 Ltr/ chi-
meric mice, but to a somewhat lesser extent than in
Tnfr1/ recipient mice. Therefore thymic damage is ex-
ecuted through TNFR1 and LTR. Finally, administration
of tgLt BM to wt mice resulted in thymic destruction
within 6 weeks after BM transplantation, ruling out intrin-
sic homing defects of tgLt thymocytes as the cause of
thymic involution. Interestingly, hemizygous crosses re-
vealed that thymic involution was partially prevented by
removing one allele of LTR but not one allele of TNFR1,
establishing a hierarchy in the signaling events leading to
thymic pathology. These results help interpreting the pre-
viously reported finding41 that T cell-specific expression
of a ligand of LTR and herpesvirus entry mediator, in-
duced thymic involution with some similarities to the phe-
notypes described here.
Efficient selection and release of CD4 and CD8 T
cells is important for both the innate and adaptive im-
mune system, suggesting that the immune competence
of tgLt mice might be compromised. Indeed, we found
a reduced capacity of the host immune system to cope
with LCMV-WE infection.
The above results raised the possibility that the acute
thymic involution induced by viral infections might be
caused by LT signaling and might be preventable by
interfering with TNFR1 signaling. Infection with either of
two LCMV strains raised LT12 expression by thymo-
cytes and TNF levels in sera and TNF and homo- as
well as heterotrimeric LT levels in wt thymi. This coincided
with thymic involution and a relative reduction of the
cortical and a concomitant increase of the medullary
thymic compartment. Moreover, we observed a reduction
of the thymus/body weight ratio and of thymocyte num-
bers. Crucially, LCMV-induced thymic involution was
greatly reduced in Tnfr1/ female mice. However, this
rescue was much less pronounced in Tnfr1/ males,
suggesting the contribution of gender-dependent factors
most likely including steroid hormones.4–7,12
Tnfr1/ mice were found to host an increased number
of thymocytes, 42 suggesting that TNF signaling may
participate both positively and negatively to the regula-
tion of thymocyte production. Alternatively, the expres-
sion of ligands to TNFR family members by T cells ap-
pears to exert a negative-trophic effect on thymic stroma,
and the resulting stromal atrophy may lead to reduced
thymocyte output from the thymus.
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Conditions that increase the expression of agonistic
TNFR1/LTR ligands by T cells may dramatically accel-
erate stromal atrophy and thymic involution. LCMV infec-
tion is an acute paradigm for such conditions. As sub-
populations of T cells resident in the thymus are likely to
experience activation at any time, it seems likely that the
phenomena outlined above may contribute to physiolog-
ical, age-dependent thymic involution.
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